Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipenem Pharmacodynamics in Febrile Neutropenia
NCT02213783Phase 4Completed
- Sponsor
- Prince of Songkla University
- Start
- Feb 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of imipenem in febrile neutropenia (FN) (2 arms), sponsored by Prince of Songkla University. Primary endpoint: Concentration of imipenem in plasma. Started Feb 2011; status: completed.
02
Drugs
imipenem
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT02213783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213783.